We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF
LABU

41 hedge funds and large institutions have $84.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

348% more capital invested

Capital invested by funds: $18.8M → $84.4M (+$65.6M)

163% more call options, than puts

Call options by funds: $246M | Put options by funds: $93.4M

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

6.56% more ownership

Funds ownership: 0.11% → 6.67% (+6.6%)

13% less funds holding

Funds holding: 47 → 41 (-6)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
11
Reduced
7
Closed
22
Calls
$246M
Puts
$93.4M
Net Calls
+$153M
Net Calls Change
+$156M

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$11.6M
2
Morgan Stanley
Morgan Stanley
New York
+$8.5M
3
Jane Street
Jane Street
New York
+$6.16M
4
Squarepoint
Squarepoint
New York
+$3.14M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$1.94M
2
Simplex Trading
Simplex Trading
Illinois
-$856K
3
IMC Chicago
IMC Chicago
Illinois
-$854K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$524K
5
Corient Private Wealth
Corient Private Wealth
Florida
-$356K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$18.5M +$11.6M +151,615 New
Morgan Stanley
2
Morgan Stanley
New York
$15.6M +$8.5M +111,138 +667%
Citadel Advisors
3
Citadel Advisors
Florida
$10.6M +$2.27M +29,688 +52%
Jane Street
4
Jane Street
New York
$9.92M +$6.16M +80,572 +10,370%
Squarepoint
5
Squarepoint
New York
$7.47M +$3.14M +41,019 +203%
TRCT
6
Tower Research Capital (TRC)
New York
$3.55M +$878K +11,473 +65%
JP Morgan Chase
7
JP Morgan Chase
New York
$3.43M +$1.06M +13,881 +97%
GS
8
GTS Securities
New York
$3.26M +$914K +11,942 +81%
Group One Trading
9
Group One Trading
Illinois
$2.25M +$1.41M +18,439 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$1.84M +$1.15M +15,077 New
Goldman Sachs
11
Goldman Sachs
New York
$1.19M +$745K +9,741 New
CG
12
Cutler Group
California
$861K +$540K +7,061 New
CIBC Private Wealth Group
13
CIBC Private Wealth Group
Georgia
$579K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$537K +$337K +4,400 New
JF
15
Jump Financial
Illinois
$521K +$327K +4,274 New
MIG
16
McGuire Investment Group
Rhode Island
$503K +$73.4K +959 +30%
SBIA
17
Sheaff Brock Investment Advisors
Indiana
$488K +$306K +4,000 New
FIA
18
Foundations Investment Advisors
Arizona
$439K -$7.73K -101 -3%
GA
19
Gateway Advisory
New Jersey
$366K +$230K +3,000 New
UBS Group
20
UBS Group
Switzerland
$351K +$220K +2,878 New
QT
21
Quantbot Technologies
New York
$327K -$89.5K -1,170 -30%
TCM
22
Traynor Capital Management
Pennsylvania
$325K +$204K +2,662 New
Wolverine Trading
23
Wolverine Trading
Illinois
$299K +$125K +1,639 +202%
SRL
24
Scientech Research LLC
New Jersey
$236K +$148K +1,936 New
PA
25
Parallel Advisors
California
$214K +$5.36K +70 +4%
1
2 3

LABU Hedge Fund Activity: Q4 2023 in Review

41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2023, worth a combined $84.4M — up 348% from $18.8M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LABU and 18 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was Barclays, opening a new position worth an estimated $11.6M. The largest seller was HRT Financial, exiting entirely with an estimated $1.94M sold.

  • 41 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2023, down from 47 in Q3 2023.
  • Funds reported $84.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2023, up 348% quarter-over-quarter.
  • 18 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2023 and 22 closed out, a net change of -4 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2023 was Barclays, an estimated $11.6M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2023 was HRT Financial, an estimated $1.94M sold.

Based on aggregated 13F filings for Q4 2023.